Patents matching “recombinant”

US 11986515

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)

REGENXBIO INC. · Granted May 21, 2024 · Expires May 16, 2044

US 11975063

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2024 · Expires May 2, 2044

US 11952429

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

US 11945855

Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

United States Government as represented by the Department of Veterans Affairs · Granted Apr 2, 2024 · Expires Mar 28, 2044

US 11918638

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

US 11904010

Recombinant virus capable of stably expressing target proteins

BOEHRINGER INGELHEIM VETMEDICA (CHINA) CO., LTD. · Granted Feb 20, 2024 · Expires Feb 15, 2044

US 11905313

Recombinant RSV G proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 20, 2024 · Expires Feb 15, 2044

CA 3260357

RÉGIME DE PRIMO-IMMUNISATION DE VIRUS DE LA VACCINE ANKARA (MVA) ET DE PETIT ARN ACTIVATEUR (VRP) MODIFIÉS RECOMBINANTS

BAVARIAN NORDIC AS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

US 11851464

Methods and compositions related to recombinant NEIL2

The Board of Regents of the University of Texas System · Granted Dec 26, 2023 · Expires Dec 21, 2043

US 11839649

Compositions comprising recombinant probiotic bacteria and methods of use thereof

United States Government as represented by the Department of Veterans Affairs · Granted Dec 12, 2023 · Expires Dec 7, 2043

US 11786591

Recombinant metapneumovirus F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11780904

Method of producing recombinant high molecular weight vWF in cell culture

Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11717565

Recombinant BCG overexpressing phoP-phoR

LTD. · Granted Aug 8, 2023 · Expires Aug 3, 2043

US 11718834

Compositions and methods for producing recombinant AAV

Sangamo Therapeutics, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

US 11707536

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

Takeda Pharmaceutical Company Limited · Granted Jul 25, 2023 · Expires Jul 20, 2043

WO 2023118508

VIRUS MVA RECOMBINANTS POUR ADMINISTRATION INTRAPÉRITONÉALE POUR LE TRAITEMENT DU CANCER

BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2023 · Expires Jun 24, 2043

WO 2023118563

THÉRAPIE POUR MODULER UNE RÉPONSE IMMUNITAIRE AU MOYEN D'UN MVA RECOMBINANT CODANT POUR IL-12

BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2023 · Expires Jun 24, 2043

US 11685771

Recombinant factor VIII proteins

BIOVERATIV THERAPEUTICS INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

US 11661593

Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

US 11613739

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells

REGENXBIO INC. · Granted Mar 28, 2023 · Expires Mar 23, 2043

US 11596671

Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression

Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11591372

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11582956

Recombinant adenovirus-based interferon biotherapeutics in swine

The United States of America, as represented by the Secretary of Agriculture · Granted Feb 21, 2023 · Expires Feb 16, 2043

US 11572413

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043